GoutNCT01151709
Assessment of Primary Care Providers' Knowledge and Beliefs Regarding Gout Management
An observational study of Gout, run by University of Massachusetts, Worcester at 1 site in United States.
Trial summary
This is a questionnaire study aimed at learning about physicians' views on the treatment of Gout. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Gout
- How many people
- 838 participants
- Where
- 1 siteUnited States
- Study dates
- Aug 2010to Feb 2012
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Primary care practitioners, both family practice and internal medicine physicians from a nationwide sample
Who may be able to join
- practicing primary care practitioner, either in family medicine or internal medicine,
- must be 18 years of age or older
Who cannot join
- does not meet inclusion criteria
Trial locations and contacts
1 site in 1 country.
United States1 site
UMass Medical School
Worcester, Massachusetts, 01566
About this study
This is a questionnaire study aimed at learning about physicians' views on the treatment of Gout.
Read the detailed description
We seek to assess the knowledge, beliefs and reported treatment practices of primary care physicians with regard to gout.
Specifically, we will:
- Assess the knowledge and beliefs with regard to acute and chronic gout management based on published treatment recommendations.
- Characterize the individuals who have knowledge deficits in terms of age, specialty, number of patients seen with gout, and practice setting.
- Assess the reported treatment practices of primary care physicians for the acute and chronic management of gout.
- Conditions
- Gout
- Keywords
- Gout, Chronic condition management, Gout management
- Medical subject headings
- Gout
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| physicians | primary care practitioners, both family practice and internal medicine physicians from a random sample of providers nationwide |
What is being measured
The primary outcome is the main question the study is designed to answer.
Assess the knowledge and beliefs with regard to acute and chronic gout management based on published treatment recommendations.
Assess physicians' knowledge and beliefs with regard to acute and chronic gout management based on published treatment recommendations by means of questionnaire.
Measured: 3 months
Characterize the individuals who have knowledge deficits in terms of age, specialty, number of patients seen with gout, and practice setting.
Characterize the individuals who have knowledge deficits in terms of age, specialty, number of patients seen with gout, and practice setting.
Measured: 3 months
Assess the reported treatment practices of primary care physicians for the acute and chronic management of gout.
Assess the reported treatment practices of primary care physicians for the acute and chronic management of gout.
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Jun 2010 (estimated)
- Study startAug 2010
- Primary completionFeb 2012
- Study completionFeb 2012
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for GoutStudies of the same condition, open and under way.
- More trials run by University of Massachusetts, WorcesterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 838 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Massachusetts, Worcester
- Sponsor type
- University, hospital or other
- Collaborators
- Takeda
- Responsible party
- Principal investigator, Leslie Harrold, University of Massachusetts, Worcester
- Investigators
- Leslie R Harrold, MD, Principal investigator, UMass Medical School
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01151709
- Sponsor's protocol ID
- 13808
- Status last verified
- Mar 2012
- First submitted
- 24 Jun 2010
- Last updated
- 7 Mar 2012
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 7 Mar 2012. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Assessment of Primary Care Providers' Knowledge and Beliefs Regarding Gout Management
- ClinicalTrials.gov ID
- NCT01151709
- Acronym / sponsor ID
- 13808
- Conditions
- Gout
- Keywords
- Gout, Chronic condition management, Gout management
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 838 participants (actual)
- Lead sponsor
- University of Massachusetts, WorcesterUniversity, hospital or other
- Collaborators
- Takeda
- Study start
- Aug 2010
- Primary completion
- Feb 2012 (actual)
- Study completion
- Feb 2012 (actual)
- First posted
- 28 Jun 2010 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a questionnaire study aimed at learning about physicians' views on the treatment of Gout.
Detailed description
We seek to assess the knowledge, beliefs and reported treatment practices of primary care physicians with regard to gout.
Specifically, we will:
- Assess the knowledge and beliefs with regard to acute and chronic gout management based on published treatment recommendations.
- Characterize the individuals who have knowledge deficits in terms of age, specialty, number of patients seen with gout, and practice setting.
- Assess the reported treatment practices of primary care physicians for the acute and chronic management of gout.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| physicians | – | –primary care practitioners, both family practice and internal medicine physicians from a random sample of providers nationwide |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Primary care practitioners, both family practice and internal medicine physicians from a nationwide sample
Key inclusion criteria (2 listed)
- practicing primary care practitioner, either in family medicine or internal medicine,
- must be 18 years of age or older
Key exclusion criteria (1 listed)
- does not meet inclusion criteria
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Assess the knowledge and beliefs with regard to acute and chronic gout management based on published treatment recommendations.
Time frame: 3 months
Assess physicians' knowledge and beliefs with regard to acute and chronic gout management based on published treatment recommendations by means of questionnaire.
Characterize the individuals who have knowledge deficits in terms of age, specialty, number of patients seen with gout, and practice setting.
Time frame: 3 months
Characterize the individuals who have knowledge deficits in terms of age, specialty, number of patients seen with gout, and practice setting.
Assess the reported treatment practices of primary care physicians for the acute and chronic management of gout.
Time frame: 3 months
Assess the reported treatment practices of primary care physicians for the acute and chronic management of gout.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Mar 2012.
Related trials for Gout
RecruitingPhase 4
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
Gout
RecruitingPhase 3
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
RecruitingPhase 3
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Tophaceous Gout
Not yet recruitingPhase 3
Combined Metabolic Activator Supplementation in Subjects Diagnosed With Gout
Gout Disease
Enrolling by invitation
The Remote Monitoring of Gout Study
Gout Initiating Urate-loweringUrate-lowering Therapy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Leslie R Harrold, MD principal investigator
UMass Medical School
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Gout, run by University of Massachusetts, Worcester at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 Mar 2012. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Assess the knowledge and beliefs with regard to acute and chronic gout management based on published treatment recommendations. (time frame: 3 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Mar 2012.